180 related articles for article (PubMed ID: 22311543)
1. Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial.
Uemura H; Sano F; Nomiya A; Yamamoto T; Nakamura M; Miyoshi Y; Miki K; Noguchi K; Egawa S; Homma Y; Kubota Y
World J Urol; 2013 Oct; 31(5):1123-8. PubMed ID: 22311543
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer.
Sano F; Terao H; Kawahara T; Miyoshi Y; Sasaki T; Noguchi K; Kubota Y; Uemura H
BJU Int; 2011 May; 107(9):1404-10. PubMed ID: 21040365
[TBL] [Abstract][Full Text] [Related]
3. Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy.
Shen WW; Cui LG; Ran WQ; Sun Y; Jiang J; Pei XL; Chen W
Ultrasound Med Biol; 2020 May; 46(5):1197-1207. PubMed ID: 32107089
[TBL] [Abstract][Full Text] [Related]
4. The utility and limitations of contrast-enhanced ultrasound for the diagnosis and treatment of prostate cancer.
Sano F; Uemura H
Sensors (Basel); 2015 Feb; 15(3):4947-57. PubMed ID: 25734645
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.
Okoro C; George AK; Siddiqui MM; Rais-Bahrami S; Walton-Diaz A; Shakir NA; Rothwax JT; Raskolnikov D; Stamatakis L; Su D; Turkbey B; Choyke PL; Merino MJ; Parnes HL; Wood BJ; Pinto PA
J Endourol; 2015 Oct; 29(10):1115-21. PubMed ID: 25897467
[TBL] [Abstract][Full Text] [Related]
6. The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer.
Fourcade A; Payrard C; Tissot V; Perrouin-Verbe MA; Demany N; Serey-Effeil S; Callerot P; Coquet JB; Doucet L; Deruelle C; Joulin V; Nonent M; Fournier G; Valeri A
Scand J Urol; 2018 Jun; 52(3):174-179. PubMed ID: 29463177
[TBL] [Abstract][Full Text] [Related]
7. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
[TBL] [Abstract][Full Text] [Related]
8. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
Wajswol E; Winoker JS; Anastos H; Falagario U; Okhawere K; Martini A; Treacy PJ; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China.
Lu DY; Liu L; Shen L; Cai JR; Xu L; Xiang LH
Clin Hemorheol Microcirc; 2021; 77(3):295-301. PubMed ID: 33252065
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
[TBL] [Abstract][Full Text] [Related]
12. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
[TBL] [Abstract][Full Text] [Related]
14. Real-time imaging of the lymphatic channels and sentinel lymph nodes of the stomach using contrast-enhanced ultrasonography with Sonazoid in a porcine model.
Kawai Y; Ajima K; Nagai T; Kaidoh M; Ohhashi T
Cancer Sci; 2011 Nov; 102(11):2073-81. PubMed ID: 21797945
[TBL] [Abstract][Full Text] [Related]
15. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
[TBL] [Abstract][Full Text] [Related]
17. The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.
Mannaerts CK; Kajtazovic A; Lodeizen OAP; Gayet M; Engelbrecht MRW; Jager GJ; Wijkstra H; de Reijke TM; Beerlage HP
Urol Oncol; 2019 May; 37(5):298.e1-298.e9. PubMed ID: 30660493
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
[TBL] [Abstract][Full Text] [Related]
19. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
[TBL] [Abstract][Full Text] [Related]
20. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
